Kinase Mobility Shift Assay (KiMSA) for Assessing Protein Kinase A Activity

The cAMP-dependent protein kinase (PKA) is one of the most extensively distributed kinases among intracellular signal cascades, with a pivotal role in the regulation of various processes, including the capacitation of sperm cells. Traditional assessments of PKA activity rely on the utilization of [γ-<sup>32</sup>P] ATP and the Kemptide peptide as a substrate. This strategy presents several major drawbacks, including high costs and health risks derived from the manipulation of radioactive isotopes. In this work, we introduce an enhanced non-radioactive assay to quantify PKA activity, termed kinase mobility shift assay (KiMSA), based on the use of a fluorescent-labeled Kemptide (Kemptide-FITC). Once the kinase reaction is terminated, the products can be easily resolved through electrophoresis on an agarose gel and quantified by fluorescence densitometry. We show that KiMSA is suitable for isolated PKA as well as for the enzyme in cell extracts. In addition, it enables quantification of PKA activity during the progression of mouse sperm capacitation. Furthermore, the assay enables monitoring the inhibition of PKA with pharmacological inhibitors in live cells. Therefore, the experimental and optimal assay conditions are set so that KiMSA can be used to assess in vitro as well as in vivo PKA activity in sperm cells. Finally, this method allows for measurement of cAMP concentrations, rendering a versatile technique for the study of cAMP/PKA pathways. Key features • KiMSA is a versatile kinase mobility shift assay for measuring PKA activity in sperm physiology, replacing radioactive assays with a fluorescence-labeled substrate for high sensitivity. • This in vitro assay enables evaluation of activation state, drug effects, or PKA kinetics after purification or mutation. • This assay measures PKA activity from cell extracts, reflecting pre-lysis activation status and intracellular signaling, though not a true in vivo readout. • The standard protocol completion time is one day, including sperm preparation, kinase reactions, electrophoresis, and fluorescence quantification.

Authors

Institutions

Publication Details

Journal
BIO-PROTOCOL
Published
2025-01-01
DOI
https://doi.org/10.21769/bioprotoc.5366
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Kinase Mobility Shift Assay (KiMSA) for Assessing Protein Kinase A Activity

Analia G. Novero, Tomás J. Steeman, Diego Krapf, Mariano G. Buffone et al.
BIO-PROTOCOL
Computational Drug Discovery Methods
article

Kinase Mobility Shift Assay (KiMSA) for Assessing Protein Kinase A Activity

Analia G. Novero, Tomás J. Steeman, Diego Krapf, Mariano G. Buffone, Darío Krapf, Andrés Binolfi, Cintia Stival, Catalina Curcio, Lara Buccolini
article en

Abstract

The cAMP-dependent protein kinase (PKA) is one of the most extensively distributed kinases among intracellular signal cascades, with a pivotal role in the regulation of various processes, including the capacitation of sperm cells. Traditional assessments of PKA activity rely on the utilization of [γ-<sup>32</sup>P] ATP and the Kemptide peptide as a substrate. This strategy presents several major drawbacks, including high costs and health risks derived from the manipulation of radioactive isotopes. In this work, we introduce an enhanced non-radioactive assay to quantify PKA activity, termed kinase mobility shift assay (KiMSA), based on the use of a fluorescent-labeled Kemptide (Kemptide-FITC). Once the kinase reaction is terminated, the products can be easily resolved through electrophoresis on an agarose gel and quantified by fluorescence densitometry. We show that KiMSA is suitable for isolated PKA as well as for the enzyme in cell extracts. In addition, it enables quantification of PKA activity during the progression of mouse sperm capacitation. Furthermore, the assay enables monitoring the inhibition of PKA with pharmacological inhibitors in live cells. Therefore, the experimental and optimal assay conditions are set so that KiMSA can be used to assess in vitro as well as in vivo PKA activity in sperm cells. Finally, this method allows for measurement of cAMP concentrations, rendering a versatile technique for the study of cAMP/PKA pathways. Key features • KiMSA is a versatile kinase mobility shift assay for measuring PKA activity in sperm physiology, replacing radioactive assays with a fluorescence-labeled substrate for high sensitivity. • This in vitro assay enables evaluation of activation state, drug effects, or PKA kinetics after purification or mutation. • This assay measures PKA activity from cell extracts, reflecting pre-lysis activation status and intracellular signaling, though not a true in vivo readout. • The standard protocol completion time is one day, including sperm preparation, kinase reactions, electrophoresis, and fluorescence quantification.

BIO-PROTOCOLVol. 15(1375)
Colorado State University (US)
Openalex Percentile: Top 85%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.